Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

73 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
European Network of Gynaecological Oncological Trial Groups' Requirements for Trials Between Academic Groups and Industry Partners--First Update 2015.
du Bois A, Reuss A, Pujade-Lauraine E, Pignata S, Ledermann J, Casado A, Sehouli J, Mirza M, Colombo N, Marth C, Witteveen E, Del Campo J, Calvert P, Aravantinos G, Vardar MA, van der Zee AG, Korach J, Taskiran C, Fehr M, Glasspool R, Pfisterer J, Cibula D, Vergote I; member trial groups of the European Network of Gynaecological Oncological Trial Groups (ENGOT). du Bois A, et al. Among authors: vardar ma. Int J Gynecol Cancer. 2015 Sep;25(7):1328-30. doi: 10.1097/IGC.0000000000000478. Int J Gynecol Cancer. 2015. PMID: 26067859
European experts consensus: BRCA/homologous recombination deficiency testing in first-line ovarian cancer.
Vergote I, González-Martín A, Ray-Coquard I, Harter P, Colombo N, Pujol P, Lorusso D, Mirza MR, Brasiuniene B, Madry R, Brenton JD, Ausems MGEM, Büttner R, Lambrechts D; European experts’ consensus group. Vergote I, et al. Ann Oncol. 2022 Mar;33(3):276-287. doi: 10.1016/j.annonc.2021.11.013. Epub 2021 Dec 1. Ann Oncol. 2022. PMID: 34861371 Free article. Review.
Side Effects from Cancer Therapies and Perspective of 1044 Long-Term Ovarian Cancer Survivors-Results of Expression VI-Carolin Meets HANNA-Holistic Analysis of Long-Term Survival with Ovarian Cancer: The International NOGGO, ENGOT, and GCIG Survey.
Woopen H, Keller M, Zocholl D, Mittelstadt S, Barretina-Ginesta MP, Heinzelmann-Schwarz V, Lafleur J, Kocián R, Baum J, Krabisch P, Achimas-Cadariu P, Vardar MA, Vergote I, Nasser S, Link T, Gil-Martin M, Zwimpfer TA, Leitner K, Jedryka M, Boxler T, Braicu EI, Sehouli J. Woopen H, et al. Among authors: vardar ma. Cancers (Basel). 2023 Nov 15;15(22):5428. doi: 10.3390/cancers15225428. Cancers (Basel). 2023. PMID: 38001688 Free PMC article.
Survival outcomes of women with grade 3 endometrioid endometrial cancer: the impact of adjuvant treatment strategies.
Gungorduk K, Muallem J, Aşıcıoğlu O, Gülseren V, Güleç ÜK, Meydanlı MM, Sehouli J, Özdemir A, Şahin H, Khatib G, Miranda A, Boran N, Şenol T, Yıldırım N, Turan T, Oge T, Taşkın S, Vardar MA, Ayhan A, Muallem MZ. Gungorduk K, et al. Among authors: vardar ma. Arch Gynecol Obstet. 2022 Mar;305(3):671-681. doi: 10.1007/s00404-021-06187-4. Epub 2021 Aug 27. Arch Gynecol Obstet. 2022. PMID: 34448946
Adenosine deaminase activity in patients with ovarian neoplasms.
Urunsak IF, Gulec UK, Paydas S, Seydaoglu G, Guzel AB, Vardar MA. Urunsak IF, et al. Among authors: vardar ma. Arch Gynecol Obstet. 2012 Jul;286(1):155-9. doi: 10.1007/s00404-012-2279-5. Epub 2012 Mar 7. Arch Gynecol Obstet. 2012. PMID: 22395862
A Turkish Gynecologic Oncology Group study of fertility-sparing treatment for early-stage endometrial cancer.
Dursun P, Erkanli S, Güzel AB, Gultekin M, Tarhan NC, Altundag O, Demirkiran F, Beşe T, Yildirim Y, Bozdag G, Yarali H, Simsek T, Ozcelik B, Ortaç F, Taskin S, Guvenal T, Ozgul N, Haberal A, Vardar MA, Dede M, Yenen M, Altintas A, Arvas M, Ayhan A. Dursun P, et al. Among authors: vardar ma. Int J Gynaecol Obstet. 2012 Dec;119(3):270-3. doi: 10.1016/j.ijgo.2012.06.010. Epub 2012 Aug 24. Int J Gynaecol Obstet. 2012. PMID: 22921272 Review.
73 results